or Try an Advanced Search...

    Technical Analysis for EVOK - Evoke Pharma, Inc.

    Grade Last Price % Change Price Change
    C 5.80 -0.85% -0.05
    EVOK closed down 0.85 percent on Friday, November 1, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Flat
    Historical EVOK trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish -0.85%
    Upper Bollinger Band Walk Strength -0.85%
    Older End-of-Day Signals for EVOK ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    200 DMA Resistance about 22 hours ago
    Up 5% about 22 hours ago
    Up 3% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    EVOK Chart by TradingView
    Basic chart:

    Profile

    Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Gastrointestinal Disorders Gastroparesis Metoclopramide Nasal Spray Prolactin Releasers

    Is EVOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Oct 28 Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis
    Oct 28 Evoke stock rockets 90% on study of Gimoti in GLP-1 users
    Oct 28 Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
    Oct 23 Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
    Oct 22 Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
    Oct 1 Evoke Pharma announces proceeds from existing warrants and board expansion
    Oct 1 Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
    Sep 19 Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
    Sep 9 Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
    See more EVOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.88
    52 Week Low 3.54
    Average Volume 468,329
    200-Day Moving Average 6.18
    50-Day Moving Average 4.91
    20-Day Moving Average 5.54
    10-Day Moving Average 5.80
    Average True Range 0.87
    RSI (14) 54.34
    ADX 43.0
    +DI 50.38
    -DI 16.99
    Chandelier Exit (Long, 3 ATRs) 9.70
    Chandelier Exit (Short, 3 ATRs) 7.43
    Upper Bollinger Bands 6.57
    Lower Bollinger Band 4.51
    Percent B (%b) 0.63
    BandWidth 37.10
    MACD Line 0.30
    MACD Signal Line 0.25
    MACD Histogram 0.0469
    Fundamentals Value
    Market Cap 19.39 Million
    Num Shares 3.34 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -2.56
    Price-to-Sales 0.58
    Price-to-Book 1.79
    PEG Ratio -0.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.40
    Resistance 3 (R3) 6.47 6.33 6.30
    Resistance 2 (R2) 6.33 6.18 6.30 6.27
    Resistance 1 (R1) 6.07 6.09 6.00 6.00 6.23
    Pivot Point 5.93 5.93 5.90 5.90 5.93
    Support 1 (S1) 5.67 5.78 5.60 5.60 5.37
    Support 2 (S2) 5.53 5.69 5.50 5.33
    Support 3 (S3) 5.27 5.53 5.30
    Support 4 (S4) 5.20